Clinical trials
Macular Degeneration trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
532 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 5 |
| 2002 | 4 |
| 2003 | 12 |
| 2004 | 14 |
| 2005 | 14 |
| 2006 | 18 |
| 2007 | 38 |
| 2008 | 28 |
| 2009 | 15 |
| 2010 | 25 |
| 2011 | 15 |
| 2012 | 33 |
| 2013 | 15 |
| 2014 | 27 |
| 2015 | 29 |
| 2016 | 17 |
| 2017 | 14 |
| 2018 | 22 |
| 2019 | 30 |
| 2020 | 25 |
| 2021 | 15 |
| 2022 | 25 |
| 2023 | 17 |
| 2024 | 14 |
| 2025 | 25 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 319 |
| Terminated | 73 |
| Recruiting | 56 |
| Unknown status | 35 |
| Active, not recruiting | 26 |
| Withdrawn | 14 |
| Enrolling by invitation | 5 |
| Not yet recruiting | 2 |
| No longer available | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 48 |
| Novartis Pharmaceuticals | 21 |
| Allergan | 13 |
| Duke University | 10 |
| GlaxoSmithKline | 10 |
| Regeneron Pharmaceuticals | 10 |
| Johns Hopkins University | 8 |
| Alcon Research | 7 |
| Genentech, Inc. | 7 |
| Ophthotech Corporation | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 532 |
| Geographic Atrophy | 77 |
| Choroidal Neovascularization | 72 |
| Retinal Diseases | 41 |
| Diabetic Retinopathy | 40 |
| Retinal Degeneration | 38 |
| Eye Diseases | 36 |
| Wet Macular Degeneration | 34 |
| Retinal Vein Occlusion | 25 |
| Glaucoma | 18 |
Trials
Showing 1 to 25 of 532. Each trial links to its page on Pharma Observatory.
432 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.